Khademi Bijan, Moradi Azadeh, Hoseini Sara, Mohammadianpanah Mohammad
Department of Otolaryngology, and Head and Neck Surgery, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz 71936-13311, Iran.
Oral Maxillofac Surg. 2009 Dec;13(4):191-9. doi: 10.1007/s10006-009-0170-8.
The present study aimed to report the characteristics, prognostic factors, and treatment outcomes of 71 cases of malignant neoplasms of the sinonasal tract and literature review and analysis of major report series.
Seventy-one consecutive patients diagnosed with primary malignant neoplasm of the sinonasal tract that were treated and followed up at a university hospital between May 2000 and March 2008 were selected for the present study. Thirty-four patients were treated with surgery followed by a combination of chemotherapy and radiotherapy, 15 with surgery alone, 14 with combined radiotherapy and chemotherapy, six with radiotherapy alone, and two with surgery followed by radiotherapy. To find out the major series of related studies over the last 20 years, a literature review of PubMed was performed. In all, we found 42 major series including 8,164 patients with malignant neoplasms of the sinonasal tract.
There were 35 women and 36 men ranging in age from 5 to 80 years, with a median age of 55 years at diagnosis. The primary sites included were paranasal sinuses in 51 and nasal cavity in 20. There were one case of stage I, 20 of stage II, 27 of stage III, and 23 of stage IV. Epithelial tumors constituted 65% of all neoplasms. After a median follow-up of 39 months for surviving patients, 33 patients are alive and without disease, eight are alive with disease, and 30 patients died due to disease. Local recurrence was the most frequent treatment failure. The 5-year disease-free, local control, and overall survival rates were 42.1%, 59.5%, and 54.5%, respectively. On univariate analysis, cervical lymph nodes involvement, primary tumor size, histologic type, response to therapy, and stage of disease were independent prognostic factors for overall survival. In the literature review and by analyzing the data collection from 42 major reported series, the median age was 57 years and male/female ratio was 1.8. Epithelial tumors consisted of 69% of all malignant neoplasms of sinonasal tract and stages III and IV disease constituted 74.7% of all stages. Local recurrence was the dominant treatment failure in nearly all series. Five-year local control and overall survival rates were 56% and 45.5%, respectively.
In this review and by analyzing the large data collection of recent major reported series, we found that malignant neoplasms of the sinonasal tract tend to present at locally advanced stage, with a high frequency of local failure and a moderate to poor outcome. More effective local treatment for improving the local control and overall survival is needed.
本研究旨在报告71例鼻窦恶性肿瘤的特征、预后因素及治疗结果,并对主要报告系列进行文献回顾与分析。
选取2000年5月至2008年3月在某大学医院接受治疗及随访的71例连续诊断为鼻窦原发性恶性肿瘤的患者。34例患者接受手术治疗,随后进行化疗和放疗联合治疗;15例仅接受手术治疗;14例接受放疗和化疗联合治疗;6例仅接受放疗;2例接受手术治疗后再进行放疗。为找出过去20年相关研究的主要系列,对PubMed进行了文献回顾。我们共找到42个主要系列,包括8164例鼻窦恶性肿瘤患者。
患者中女性35例,男性36例,年龄5至80岁,诊断时中位年龄为55岁。原发部位包括鼻窦51例,鼻腔20例。Ⅰ期1例,Ⅱ期20例,Ⅲ期27例,Ⅳ期23例。上皮性肿瘤占所有肿瘤的65%。存活患者中位随访39个月后,33例患者无病存活,8例带瘤存活,30例患者因病死亡。局部复发是最常见的治疗失败情况。5年无病生存率、局部控制率和总生存率分别为42.1%、59.5%和54.5%。单因素分析显示,颈部淋巴结受累、原发肿瘤大小、组织学类型、对治疗的反应及疾病分期是总生存的独立预后因素。在文献回顾及对42个主要报告系列收集的数据进行分析时,中位年龄为57岁,男女比例为1.8。上皮性肿瘤占鼻窦所有恶性肿瘤的69%,Ⅲ期和Ⅳ期疾病占所有分期的74.7%。几乎在所有系列中,局部复发都是主要的治疗失败情况。5年局部控制率和总生存率分别为56%和45.5%。
在本综述及对近期主要报告系列的大量数据收集分析中,我们发现鼻窦恶性肿瘤倾向于在局部晚期出现,局部失败频率高,预后中等至较差。需要更有效的局部治疗以提高局部控制率和总生存率。